Life Sciences
WIT focuses on building teams of leading life sciences testifying experts from academia, industry, and government to address the needs of our clients in the pharmaceutical, biotechnology, and healthcare technology industries.
WIT regularly takes on bet-the-company litigation and stays ahead of the curve when it comes to the medical, legal, and technical issues at the core of life sciences disputes so that we can efficiently support attorneys as they assess and address their clients’ litigation and regulatory risks.
Areas of Focus
WIT anticipates future litigation trends in emerging areas of life sciences and builds diverse teams of experts that can best inform and advise our clients. We take a proactive approach to deliver insight from leading experts across these industries and look at arising trends in litigation within each sector as well as issues that converge across them.
- Biologic Drugs
- Clinical trial design and monitoring
- CMC and cGMP compliance
- Distribution and pricing
- Generics
- Labeling and advertising
- Manufacturing processes
- OTC drugs
- Research and development
- Vaccines
WIT has been involved in many of the largest product liability cases in recent history including on behalf of dozens of parties in the Opioid MDL. Many of our experts are former pharmaceutical executives whose experience spans everything from product development to corporate transactions.
- Computing platforms
- Data processing, storage, and security
- Digital health apps and monitoring technology
- Fitness trackers
- Healthcare policies and procedures
- Sensors
- Smartwatches
- Telehealth
- Wearable devices
- Wireless connectivity
WIT has built teams of world-class experts who understand the hardware and software in rapidly advancing healthcare technology and the legal strategies involved in disputes.
- Batteries
- Data Processing and Privacy
- Device Design, Functionality, and Performance
- Distribution and Pricing Strategies
- Healthcare Policies and Procedures
- Labeling and Advertising
- Manufacturing Processes
- Related Software
- Sensors and Trackers
- Wireless Connectivity and Power Transfer
WIT represents highly qualified experts specializing in medical devices who understand the issues and nuances associated with the research, development, and manufacturing of these products.
Top Trends
Our Experts
WIT represents esteemed academics, former regulators, and industry veterans experienced in the pharmaceutical, biotechnology, and healthcare technology industries. Our expert teams are ready to support you through every stage of litigation providing insights essential to success in any dispute. Our experts’ specialties feature:
- Bacteriology
- Biomedical Engineering
- Biostatistics
- Biotechnology
- Drug Licensing
- Epidemiology
- FCA/Qui Tam
- Former FDA, CDC, HHS, NIH, NCPDCID, NIAID
- Formulations
- Genetics
- Healthcare Compliance
- Healthcare Economists
- Materials Science
- Medical Doctors
- Microbiology
- Outbreak/Pandemic
- Pharmacology
- Pharmacokinetics & PBPK Modeling
- Pharmacodynamics
- Pharmaceutical Marketing
- Pharmacy Executives
- Proteomics
- Toxicology
- Virology
Hatch-Waxman Litigation
In an era where innovation in life sciences is advancing rapidly, intellectual property matters in the pharmaceutical industry have grown increasingly complex. WIT has extensive experience working on cases involving Abbreviated New Drug Applications (ANDAs) and understands the complexities associated with the Hatch-Waxman Act.
We affiliate with leading experts in life sciences and drug development to best advise our clients. Our ANDA expert team includes pharma professionals with diverse backgrounds in pharmaceutical sciences who can explain complex drug formulations, manufacturing processes, and the science behind the drug’s action.
